BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Alterity Therapeutics Announces Late-Breaker Oral Presentation at the American Academy of Neurology Annual Meeting

  April 16, 2026

   · 

  3 min read
• Press Releases

  Adlai Nortye Announces $150.0 Million Private Placement Equity Financing

  April 16, 2026

   · 

  4 min read
• Press Releases

  ZYUS Life Sciences Announces Completion of the Final Study Visit by the Last Patient in Phase 2a UTOPIA-1 Trial Evaluating Novel Non-Opioid Pain Drug

  April 16, 2026

   · 

  4 min read
• Press Releases

  Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

  April 16, 2026

   · 

  6 min read
• Press Releases

  Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences

  April 16, 2026

   · 

  4 min read
• Press Releases

  Microbix Presenting at the 2026 Bloom Burton Conference

  April 16, 2026

   · 

  4 min read
• Press Releases

  Helsinn appoints Giacomo Braglia to the Board of Directors

  April 16, 2026

   · 

  2 min read
• Press Releases

  Araceli Biosciences Appoints Christine Tsingos to Board of Directors

  April 16, 2026

   · 

  2 min read
• Press Releases

  Ardelyx to Report First Quarter 2026 Financial Results on April 30, 2026

  April 16, 2026

   · 

  1 min read
• Press Releases

  ACHIEVE-4, the longest Phase 3 study of Lilly’s Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of cardiometabolic health

  April 16, 2026

   · 

  15 min read